Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

MTEM

Molecular Templates (MTEM)

Molecular Templates Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MTEM
FechaHoraFuenteTítuloSímboloCompañía
15/11/202405:05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:MTEMMolecular Templates Inc
12/11/202408:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MTEMMolecular Templates Inc
28/10/202416:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MTEMMolecular Templates Inc
17/10/202416:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MTEMMolecular Templates Inc
11/10/202415:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
30/09/202416:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
14/08/202415:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MTEMMolecular Templates Inc
14/08/202415:21GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
13/08/202415:47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MTEMMolecular Templates Inc
13/08/202415:44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MTEMMolecular Templates Inc
03/06/202407:11GlobeNewswire Inc.Molecular Templates, Inc. Provides Interim UpdateNASDAQ:MTEMMolecular Templates Inc
15/05/202416:11GlobeNewswire Inc.Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
09/04/202407:11GlobeNewswire Inc.Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer PatienNASDAQ:MTEMMolecular Templates Inc
29/03/202407:21GlobeNewswire Inc.Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
28/03/202407:11GlobeNewswire Inc.Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementNASDAQ:MTEMMolecular Templates Inc
14/02/202419:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTEMMolecular Templates Inc
14/02/202415:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTEMMolecular Templates Inc
08/02/202416:55GlobeNewswire Inc.Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:MTEMMolecular Templates Inc
13/11/202315:11GlobeNewswire Inc.Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/11/202315:11GlobeNewswire Inc.Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid TumorsNASDAQ:MTEMMolecular Templates Inc
01/11/202315:12GlobeNewswire Inc.Molecular Templates to Participate in Upcoming Investor ConferencesNASDAQ:MTEMMolecular Templates Inc
06/10/202316:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
28/09/202315:11GlobeNewswire Inc.Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerNASDAQ:MTEMMolecular Templates Inc
20/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTEMMolecular Templates Inc
11/08/202310:22GlobeNewswire Inc.Molecular Templates Announces 1-for-15 Reverse Stock SplitNASDAQ:MTEMMolecular Templates Inc
10/08/202308:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MTEMMolecular Templates Inc
10/08/202307:08GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/08/202315:11GlobeNewswire Inc.Molecular Templates Announces Executive Leadership ChangesNASDAQ:MTEMMolecular Templates Inc
31/07/202315:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:MTEMMolecular Templates Inc
13/07/202307:14GlobeNewswire Inc.Molecular Templates Announces Up to $40 Million Private Placement OfferingNASDAQ:MTEMMolecular Templates Inc
 Showing the most relevant articles for your search:NASDAQ:MTEM